At 10:43 AM, the Nifty Pharma index was down 4% as compared to a marginal 0.14% decline in the Nifty 50 index
The stock dipped 7% to Rs 1,736 on the BSE in intra-day trade.
US business contributes around 45% of Lupin's revenue.